Back to search
FDAFDA · Food and drugs·Recall number D-0654-2021

Poseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0 95842 05876 0

Published July 21, 2021 · Recall initiated: May 11, 2021

Summary

FDA records drug Class I recall D-0654-2021, published July 21, 2021 and initiated May 11, 2021. Recalling firm: Yamtun7; Status: Terminated; Reported quantity: 36 capsules; Lot: All lots distributed 07/01/2019 through 09/28/2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Yamtun7
Distributor
Unknown; unable to determine due to firm's Ebay account being closed.
Lot
All lots distributed 07/01/2019 through 09/28/2020.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Poseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0 95842 05876 0 recalled?

Yes. FDA published recall D-0654-2021 on July 21, 2021. Reported hazard: Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release